Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck and Endocyte say EU is reviewing vintafolide as a treatment for ovarian cancer
Merck and Endocyte say EU is reviewing vintafolide as a treatment for ovarian cancer
Merck and Endocyte say EU is reviewing vintafolide as a treatment for ovarian cancer
Submitted by
admin
on November 27, 2012 - 1:08pm
Source:
Yahoo/AP
News Tags:
Merck
Endocyte
Europe
vintafolide
ovarian cancer
Headline:
Merck and Endocyte say EU is reviewing vintafolide as a treatment for ovarian cancer
Do Not Allow Advertisers to Use My Personal information
